Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
143M
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
+10.1M
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
-$75.9M
-
Put/Call ratio
-
0.21
-
Number of buys
-
126
-
Number of sells
-
-87
-
Price
-
$10.46
Significant Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q1 2025
255 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock as of Q1 2025.
Dyne Therapeutics, Inc. - Common Stock (DYN) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 143M outstanding shares and own 85.45% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (10.4M shares), RA CAPITAL MANAGEMENT, L.P. (9.71M shares), Atlas Venture Life Science Advisors, LLC (9.13M shares), BlackRock, Inc. (8.05M shares), VANGUARD GROUP INC (7.41M shares), FCPM III SERVICES B.V. (5.46M shares), FMR LLC (5.2M shares), BRAIDWELL LP (3.62M shares), STATE STREET CORP (3.61M shares), and CITADEL ADVISORS LLC (3.01M shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.